Showing results (1551-1560 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 10, 2000
Gene therapy of chronic granulomatous diseaseM Grez, S Becker, S Saulnier, et al.
Bone Marrow Transplantation|August 10, 2000
Engineering drug resistance in human cellsL J Fairbairn, J A Rafferty, L S Lashford
Bone Marrow Transplantation|August 10, 2000
Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cellsB Schiedlmeier, K Wermann, K Kühlcke, et al.
Bone Marrow Transplantation|October 24, 2000
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantationJ D Lickliter, P B McGlave, T E DeFor, et al.
Bone Marrow Transplantation|October 24, 2000
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcomeS Shiobara, S Nakao, M Ueda, et al.
Bone Marrow Transplantation|October 24, 2000
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patientS Tauro, V Toh, H Osman, et al.
Bone Marrow Transplantation|October 24, 2000
Cyclosporin A-related cerebral vasculopathyR M Shbarou, N J Chao, J C Morgenlander
Bone Marrow Transplantation|October 24, 2000
Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantationS Imoto, T Murayama, H Gomyo, et al.
Bone Marrow Transplantation|October 24, 2000
Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donorsW Hilbe, W Nussbaumer, H Bonatti, et al.
Bone Marrow Transplantation|November 13, 2001
Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector populationS Maury, K Belhadj, I Chami, et al.
Pageof 993